| Prev Close | 17.70 |
| Open | 17.75 |
| Day Low/High | 17.50 / 17.80 |
| 52 Wk Low/High | 11.00 / 18.00 |
| Volume | 25.00K |
| Avg Volume | 52.60K |
| Exchange | NASDAQ |
| Shares Outstanding | 17.33M |
| Market Cap | 304.07M |
| EPS | 0.30 |
| P/E Ratio | 48.75 |
| Div & Yield | 0.24 (1.25%) |
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the second quarter of its 2018 fiscal year, the period ended February 28, 2018, on Monday, April 9, 2018.
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical development from earliest discovery through all phases of clinical trials, today...
Cognigen Corporation, a Simulations Plus company (NASDAQ: SLP) and a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that it has released Version 2 of its...
Looking at the universe of stocks we cover at Dividend Channel, on 1/25/18, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.06, payable on 2/2/18.
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development, today announced that its board of directors...
DILIsym Service, Inc., a Simulations Plus company (NASDAQ: SLP) and a leading provider of simulation and modeling software for pharmaceutical safety and efficacy, today announced that it has released Version 7A of its...
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for all stages of pharmaceutical discovery and development from the earliest discovery through all...
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the first quarter of its 2018 fiscal year on Tuesday, January 9, 2018.
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, chemicals, and consumer goods industries, today announced that it has released version 8.
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today announced that chairman and chief executive officer, Walt Woltosz, will present at the 10th annual LD...
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for pharmaceutical discovery and development, today reported its financial results for its 2017 fiscal year (FY17) and fourth quarter (4Q17) ended August...
Looking at the universe of stocks we cover at Dividend Channel, on 11/10/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.06, payable on 11/20/17.
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file Form 10-K for the 2017 fiscal year ended August 31, 2017, with the U.
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced changes in its senior management structure.
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, chemicals, and consumer goods industries, today announced that it has released version 2 of its in...
DILIsym Services Inc., a Simulations Plus company (NASDAQ: SLP) and a leading provider of simulation and modeling software for pharmaceutical safety and efficacy, today announced that it has released Version 6A of its...
Looking at the universe of stocks we cover at Dividend Channel, on 7/26/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 8/4/17.
Catching a decent wave more about luck than skill.
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and chemicals industries, today announced that its board of...
Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...
Simulations Plus, Inc. (Nasdaq:SLP) announced today that it expects to file its quarterly report on Form 10-Q for the third quarter of its 2017 fiscal year, the period ended May 31, 2017, on Monday, July 10, 2017.
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for the third quarter of its fiscal year 2017,...
Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that the Stock Purchase Agreement (the "Agreement") with DILIsym...
Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced that it will be presenting at the 7 th Annual LD...
Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical...
Looking at the universe of stocks we cover at Dividend Channel, on 5/4/17, Simulations Plus Inc. will trade ex-dividend, for its quarterly dividend of $0.05, payable on 5/15/17.
